Dr. Otto Orlean Yang, MD

Dr. Yang practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Yang's NPI, 1780604298, was assigned on July 20, 2006. Dr. Yang graduated from The Warren Alpert Medical School of Brown University in 1990. Dr. Yang holds California license G85572.

Dr. Yang's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Yang's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dr. Yang is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Yang to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yang practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Yang's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Yang is licensed in California.

CMS data shows 144 Medicare services from Dr. Yang across 5 procedure codes in 2024, for 91 Medicare patients. Medicare paid $14,168 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Dr. Yang in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 4.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yang's median patient age at 60, with 51% women.

In 2024, Dr. Yang wrote 82 Medicare Part D claims for 27 patients. 51% of them were for generic drugs. CMS names the drug for 27 of them, across 1 drug with 11 or more claims each, at $3,033 in total drug cost. In 2023, CMS named 43 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Yang for performance year 2024, reported as part of a group. Dr. Yang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yang as offering telehealth.

Dmand AI links 64 papers to Dr. Yang, published from 2001 to 2024. 2014 was the busiest year, with 7. The most frequent topics are SARS-CoV-2, Antibodies, Viral and COVID-19. Dr. Yang has published most often in J Infect Dis. Dr. Yang's most frequent co-authors are Theodoros Kelesidis, MD, Judith Silverstein Currier, MD and Jennifer A. Fulcher, MD, PhD.

Dmand AI links Dr. Yang to 7 clinical trials, 4 of them phase 2 studies. Conditions studied include COVID-19 and Pneumonia, Viral. CytoDyn, Inc. sponsors the most, 3.

CMS Open Payments shows 74 general payments to Dr. Yang from 3 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Applied Medical Corporation paid the most, $516,615.

Dmand AI lists 1 award for Dr. Yang, most recently CMS Stage 1 EHR in 2013.

Dr. Yang graduated from The Warren Alpert Medical School of Brown University in 1990.

Dr. Yang is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.